Skip to main content

Advertisement

SpringerLink
Log in

The role of pharmacotherapy in assisting smoking cessation

  • Review Article
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Tobacco use represents the single most important preventable health hazard world-wide. Its consumption confers substantially increased mortality and morbidity due to cardiovascular, cerebrovascular and respiratory disease, and malignancy in a number of sites. A key goal towards improving public health in developing and developed countries alike is to reduce tobacco use across populations. Despite this, current data suggest that global tobacco use is increasing. There have been recent pharmacological advances that offer the hope of achieving more effective tobacco cessation and reduced consumption among established tobacco users. These are discussed in further detail, with reference to evidence supporting their use in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rigotti NA (2002) Clinical practice. Treatment of tobacco use and dependence. N Engl J Med 346:506–512

    Article  PubMed  Google Scholar 

  2. Raw M, McNeill A, West R (1998) Smoking cessation guidelines for health professionals. A guide to effective smoking cessation interventions for the health care system. Thorax 53:S1–S19

    Google Scholar 

  3. World Health Organization (1997) Tobacco or health: a global status report. WHO, Geneva

    Google Scholar 

  4. Smith CJ, Livingston SD, Doolittle DJ (1997) An international literature survey of IARC Group I carcinogens reported in mainstream cigarette smoke. Food Chem Toxicol 35:1107–1130

    Article  CAS  PubMed  Google Scholar 

  5. Hecht SS (1999) Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91:1194–1210

    Article  CAS  PubMed  Google Scholar 

  6. Chiang VL, Castleden WM, Leahy MF (1992) Detection of reversible platelet aggregates in the blood of smokers and ex-smokers with peripheral vascular disease. Med J Aust 156:601–603

    CAS  PubMed  Google Scholar 

  7. Pilz H, Oguogho A, Chehne F, Lupattelli G, Palumbo B, Sinzinger H (2000) Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury determined via plasma, serum and urinary isoprostane. Thromb Res 99:209–221

    Article  CAS  PubMed  Google Scholar 

  8. Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S (1985) The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 313:1511–1514

    CAS  PubMed  Google Scholar 

  9. Samet JM (1992) The health benefits of smoking cessation. Med Clin North Am 76:399–414

    CAS  PubMed  Google Scholar 

  10. Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, Hunter DJ, Hennekens CH, Speizer FE (1993) Smoking cessation in relation to total mortality rates in women. A prospective cohort study. Ann Intern Med 119:992–1000

    CAS  PubMed  Google Scholar 

  11. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA Jr, Enright PL, Kanner RE, O'Hara P, et al (1994) Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 272:1497–1505

    Article  CAS  PubMed  Google Scholar 

  12. Colby SM, Tiffany ST, Shiffman S, Niaura RS (2000). Are adolescent smokers dependent on nicotine? A review of the evidence. Drug Alcohol Depend 59:S83–S95

    PubMed  Google Scholar 

  13. Stanton WR. (1995) DSM-III-R tobacco dependence and quitting during late adolescence. Addict Behav 20:595–603

    Article  CAS  PubMed  Google Scholar 

  14. Robins LN, Helzer JE, Croughan J, Ratcliff KS (1981) National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch Gen Psychiatry 38:381–389

    CAS  PubMed  Google Scholar 

  15. Fagerstrom KO (1978) Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 3:235–241

    PubMed  Google Scholar 

  16. Hughes JR, Gulliver SB, Fenwick JW, Valliere WA, Cruser K, Pepper S, Shea P, Solomon LJ, Flynn BS (1992) Smoking cessation among self-quitters. Health Psychol 11:331–334

    CAS  PubMed  Google Scholar 

  17. Garvey AJ, Kinnunen T, Nordstrom BL, Utman CH, Doherty K, Rosner B, Vokonas PS (2000) Effects of nicotine gum dose by level of nicotine dependence. Nicotine Tob Res 2:53–63

    Article  CAS  PubMed  Google Scholar 

  18. Fiore MC, Smith SS, Jorenby DE, Baker TB (1994) The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. JAMA 271:1940–1947

    CAS  PubMed  Google Scholar 

  19. Imperial Cancer Research Fund General Practice Research Group (1994) Randomised trial of nicotine patches in general practice: results at one year. Br Med J 308:1476–1477

    Google Scholar 

  20. Daughton DM, Fortmann SP, Glover ED, Hatsukami DK, Heatley SA, Lichtenstein E, Repsher L, Millatmal T, Killen JD, Nowak RT, Ullrich F, Patil KD, Rennard SI (1999) The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Prev Med 28:113–118

    Article  CAS  PubMed  Google Scholar 

  21. Fiore MC, Kenford SL, Jorenby DE, Wetter DW, Smith SS, Baker TB (1994) Two studies of the clinical effectiveness of the nicotine patch with different counselling treatments. Chest 105:524–533

    CAS  PubMed  Google Scholar 

  22. Sutherland G, Stapleton JA, Russell MA, Jarvis MJ, Hajek P, Belcher M, Feyerabend C (1992) Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 340:324–329

    PubMed  Google Scholar 

  23. Hjalmarson A, Nilsson F, Sjostrom L, Wiklund O (1997) The nicotine inhaler in smoking cessation. Arch Intern Med 157:1721–1728

    Article  CAS  PubMed  Google Scholar 

  24. Dacosta A, Guy JM, Tardy B, Gonthier R, Denis L, Lamaud M, Cerisier A, Verneyre H (1993) Myocardial infarction and nicotine patch: a contributing or causative factor? Eur Heart J 14:1709–1711

    Google Scholar 

  25. Ferry LH, Burchette RJ (1994) Efficacy of bupropion for smoking cessation in non. depressed smokers. J Addict Dis 13:249

    Google Scholar 

  26. Ascher JA, Cole JO, Colin JN, Feighner JP, Ferris RM, Fibiger HC, Golden RN, Martin P, Potter WZ, Richelson E et al. (1995) Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 56:395–401

    CAS  PubMed  Google Scholar 

  27. Hughes JR, Goldstein MG, Hurt RD, Shiffman S (1999) Recent advances in the pharmacotherapy of smoking. JAMA 281:72–76

    CAS  PubMed  Google Scholar 

  28. Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337:1195–1202

    CAS  PubMed  Google Scholar 

  29. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340:685–691

    CAS  PubMed  Google Scholar 

  30. Coleman T (2001) Smoking cessation: integrating recent advances into clinical practice. Thorax 56:579–582

    Article  CAS  PubMed  Google Scholar 

  31. Bohadana A, Nilsson F, Rasmussen T, Martinet Y (2000) Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 160:3128–3334

    Article  CAS  PubMed  Google Scholar 

  32. Coleman T, West R (2001) Newly available treatments for nicotine addiction. Smokers wanting help with stopping now have effective treatment options. Br Med J 322:1076–1077

    Article  CAS  Google Scholar 

  33. Settle EC Jr (1998) Bupropion sustained release: side effect profile. J Clin Psychiatry 59:32–36

    CAS  Google Scholar 

  34. Covey LS, Sullivan MA, Johnston JA, Glassman AH, Robinson MD, Adams DP (2000) Advances in non-nicotine pharmacotherapy for smoking cessation. Drugs 59:17–31

    CAS  Google Scholar 

  35. Woolacott NF, Jones L, Forbes CA, Mather LC, Sowden AJ, Song FJ, Raferty JP, Aveyard PN, Hyde CJ, Barton PM (2002) The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technol Assess 6:1–245

    CAS  Google Scholar 

  36. Ranson MK, Jha P, Chaloupka FJ, Nguyen SN (2002) Global and regional estimates of the effectiveness and cost-effectiveness of price increases and other tobacco control policies. Nicotine Tob Res 4:311–319

    Article  PubMed  Google Scholar 

  37. West JA (1997) Cost-effective strategies for the management of vascular disease. Vasc Med 2:25–29

    CAS  PubMed  Google Scholar 

  38. Britton J, Jarvis MJ (2000) Bupropion: a new treatment for smokers. Br Med J 321:65–66

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Pharmacology Unit, The University of Edinburgh, Western General Hospital, Crewe Road, EH4 2XU, Edinburgh, Scotland, UK

    W. Stephen Waring

Authors
  1. W. Stephen Waring
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. Stephen Waring.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waring, W.S. The role of pharmacotherapy in assisting smoking cessation. Eur J Clin Pharmacol 59, 351–356 (2003). https://doi.org/10.1007/s00228-003-0632-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-003-0632-0

Keywords

Search

Navigation